Invention Grant
- Patent Title: Klebsiella pneumoniae O3 specific antibodies
-
Application No.: US16321523Application Date: 2017-08-11
-
Publication No.: US10759848B2Publication Date: 2020-09-01
- Inventor: Valeria Szijárto , Gábor Nagy , Luis Guachalla , Katharina Ramoni , Adriana Badarau , Eszter Nagy , Tim Rollenske , Hedda Wardemann , Irina Mirkina
- Applicant: ARSANIS Biosciences GmbH , Max-Planck-Gesellschaft zur Förderung der Wissenschafter e. V.
- Applicant Address: AT Vienna DE Munich
- Assignee: ARSANIS Biosciences GmbH,Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V.
- Current Assignee: ARSANIS Biosciences GmbH,Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V.
- Current Assignee Address: AT Vienna DE Munich
- Agency: Maier & Maier, PLLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@902ad44 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@f8a8fa9
- International Application: PCT/EP2017/070446 WO 20170811
- International Announcement: WO2018/029346 WO 20180215
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/12 ; A61P31/04 ; A61K39/00
Abstract:
A cross-neutralizing monoclonal antibody that specifically recognizes a cross-reactive epitope of the lipopolysaccharide (LPS) antigen structure of Klebsiella pneumoniae, which is an O3b epitope, cross-reacting with an O3a epitope and an O3 epitope, wherein the antibody is characterized by specific CDR sequences or VH and VL sequences.
Public/Granted literature
- US20190153077A1 KLEBSIELLA PNEUMONIAE O3 SPECIFIC ANTIBODIES Public/Granted day:2019-05-23
Information query
